Biotechnology News

Zweite Phase-2-Studie initiiert, die auf BioNTechs unternehmenseigener individualisierter mRNA-basierten Krebsimpfstoff-Plattform iNeST basiert Randomisierte Phase-2-Studie wird rund 200 Patienten mit...

Second Phase 2 trial initiated from BioNTech’s proprietary individualized mRNA-based cancer vaccine platform iNeST Randomized Phase 2 trial will enroll approximately 200 patients with high-risk...

Ad hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 1. Oktober 2021 -SIX Exchange Regulation hat Santhera gestattet, den Zwischenberichts für die sechs Monate bis zum 30. Juni 2021 spätestens am...

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, October 1, 2021 : SIX Exchange Regulation has permitted Santhera to publish its interim report for the six-month period ended...

BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...

SAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced...

CAMBRIDGE, Mass. and NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of...

SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer,...

BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...